Form4insider filings, from the source

SEC Form 4 · accession 0000874015-16-000102

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Sarah Boyce
Officer — Chief Business Officer
Period of report
Jan 15, 2016
Accepted (ET)
Jan 19, 2016 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2016M2,188$0.00A2,607D
Common StockF2Jan 19, 2016S872$41.4574D1,735D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4—Jan 15, 2016A5,178A——Common Stock5,1785,178D
Restricted Stock UnitsF2,F3,F5—Jan 15, 2016M2,188D——Common Stock2,1886,562D

Explanation of responses